Richard W. Beck, MD
Physician, Internal Medicine
About
Publications While At HealthPartners
selected publications
Journal Article
  • Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial. 
    JAMA network open. 2025
  • Continuous glucose monitoring-measured glucose levels during oral glucose tolerance testing in pregnancy. 
    Diabetes Technology & Therapeutics. 2025
  • Patient-reported outcomes improve with a virtual diabetes care model that includes continuous glucose monitoring. 
    Telemedicine Journal and e-Health. 2025
  • A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL. 
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications. 
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. 
    Diabetes care. 2024
  • Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes. 
    Obstetrics and Gynecology. 2024
  • Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. 
    BMJ open diabetes research & care. 2024
  • A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • Assessment of the glucose management indicator using different sampling durations. 
    Diabetes Technology & Therapeutics. 2023
  • Comprehensive telehealth model to support diabetes self-management. 
    JAMA network open. 2023
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 
    Endocrine Reviews. 2023
  • The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring. 
    Diabetes Technology & Therapeutics. 2023
  • A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 
    Diabetes Technology & Therapeutics. 2022
  • Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. 
    Diabetes Technology & Therapeutics. 2022
  • The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial. 
    Diabetes Technology & Therapeutics. 2022
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 
    Lancet (London, England). 2021
  • Beyond A1C-standardization of continuous glucose monitoring reporting: why it is needed and how it continues to evolve. 
    Diabetes Spectrum. 2021
  • Continuous glucose monitoring and glycemic control in patients with type 2 diabetes treated with basal insulin-reply. 
    JAMA. 2021
  • Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 
    JAMA. 2021
  • Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data. 
    Diabetes, Obesity & Metabolism. 2021
  • Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. 
    Diabetes Technology & Therapeutics. 2021
  • Real-world, patient-reported and clinic data from individuals with type 1 diabetes using the MiniMed 670G hybrid closed-loop system. 
    Diabetes Technology & Therapeutics. 2021
  • The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 
    Diabetes care. 2021
  • Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 
    Journal of the Endocrine Society. 2020
  • Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • . 2018;41:2275-2280. 
    Diabetes care. 2019
  • Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. 
    Journal of Clinical Endocrinology and Metabolism. 2019
  • Emphasizing optimal diabetes management for all races/ethnicities, but not race/ethnicity-specific cut points for hemoglobin A1c. 
    JAMA ophthalmology. 2019
  • State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. 
    Diabetes Technology & Therapeutics. 2019
  • The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set. 
    Diabetes Technology & Therapeutics. 2019
  • The relationships between time in range, hyperglycemia metrics, and HbA1c. 
    Journal of Diabetes Science and Technology. 2019
  • Validation of time in range as an outcome measure for diabetes clinical trials. 
    Diabetes care. 2019
  • Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. 
    Lancet (London, England). 2018
  • Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. 
    Diabetes care. 2018
  • Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control. 
    Diabetes Technology & Therapeutics. 2018
  • Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. 
    Annals of Internal Medicine. 2017
  • Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND Randomized Clinical Trial. 
    JAMA. 2017
  • Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial. 
    The lancet. Diabetes & endocrinology. 2017
  • REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 
    Diabetes care. 2017
  • Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. 
    Annals of Internal Medicine. 2017
  • The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. 
    Diabetes care. 2017
  • Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. 
    Pediatric Diabetes. 2016
  • Hypoglycemia in older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2016
  • Risk factors associated with severe hypoglycemia in older adults with type 1 diabetes. 
    Diabetes care. 2016
  • Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic registry. 
    Diabetes care. 2015
  • Obesity in youth with type 1 diabetes in Germany, Austria, and the United States. 
    Journal of Pediatrics. 2015
  • Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. 
    Diabetes care. 2015
  • Depression in adults in the T1D Exchange Clinic Registry. 
    Diabetes care. 2014
  • Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. 
    Diabetes care. 2014
  • Challenges and future directions of the T1D Exchange Clinic Network and registry. 
    Journal of Diabetes Science and Technology. 2013
  • Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry. 
    Journal of Diabetes. 2013
  • Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry. 
    Diabetes care. 2013
  • Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. 
    Diabetes care. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). 
    Diabetes Technology & Therapeutics. 2013
  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. 
    Journal of Diabetes Science and Technology. 2013
  • Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. 
    Journal of Clinical Endocrinology and Metabolism. 2013
  • The T1D Exchange clinic registry. 
    Journal of Clinical Endocrinology and Metabolism. 2012
    • Editorial Article
  • The Glucose Management Indicator: time to change course [editorial]?. 
    Diabetes care.  47. 2024
  • Continuous glucose monitoring for type 2 diabetes: how does it compare with type 1 diabetes [editorial]?. 
    Diabetes Technology & Therapeutics.  24. 2022
  • Glucose management indicator (GMI): insights and validation using Guardian 3 and Navigator 2 sensor data [editorial]. 
    Diabetes care.  42. 2019
  • Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels [editorial]. 
    Annals of Internal Medicine.  168. 2018
  • Continuous glucose monitoring in patients with type 1 diabetes using insulin injections [editorial]. 
    Diabetes care.  39. 2016
    • Conference Poster
  • Hybrid closed-loop in adults with type 1 diabetes: impact of baseline A1c on glucose outcomes and insulin delivery [poster]
    2019
    • Review
  • Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [review]. 
    The lancet. Diabetes & endocrinology. 2023
  • Advances in technology for management of type 1 diabetes [review]. 
    Lancet (London, England). 2019
  • Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time-in-Range [review]. 
    Diabetes care. 2019
  • International consensus on use of continuous glucose monitoring [review]. 
    Diabetes care. 2017
    • Abstract
  • Cross-study comparisons done right: an illustration using two pivotal trials of closed-loop systems [abstract]. 
    Diabetes. 2020
  • Factors associated with reduced hypoglycemia awareness (RHA) in older adults with type 1 diabetes (T1D) [abstract]. 
    Diabetes. 2015
  • Hypoglycemia and glucose variability in older adults with type 1 diabetes (T1D) [abstract 408-P]. 
    Diabetes. 2015
    • Contact
    full name
  • Richard W. Beck, MD
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration